Literature DB >> 26609034

Haematological profile of 21 patients with hairy cell leukaemia in a tertiary care centre of north India.

Arvind Kumar Gupta, Man Updesh Singh Sachdeva1, Jasmina Ahluwalia, Reena Das, Shano Naseem, Prashant Sharma, Narender Kumar, Pankaj Malhotra, Neelam Varma, Subhash Varma.   

Abstract

BACKGROUND &
OBJECTIVES: Hairy cell leukaemia (HCL) is a B cell neoplasm which constitutes around 2 per cent of all the lymphoid leukaemias. It has a characteristic morphology and immunophenotypic profile. It is important to distinguish HCL from other B cell lymphoproliferative disorders due to availability of different chemotherapeutic agents. This study presents clinical, haematological and immunophenotypic profile of patients with HCL seen over a period of four years in a tertiary care hospital in north India.
METHODS: Twenty one cases of hairy cell leukaemia were analyzed for their clinical details, haemogram, bone marrow examination and immunophenotypic findings.
RESULTS: Age of the patients ranged from 28-76 yr with male predominance. Weakness and fever were commonest presentations. Splenomegaly, hepatomegaly, lymphadenopathy were seen in decreasing order of frequency. Anaemia was noted in all 21 patients, leukopenia in 15 and thrombocytopenia in 19 cases. Fourteen patients were pancytopenic. Bone marrow examination showed typical hairy cells in all cases. Immunophenotyping showed expression of CD19, CD20, CD103, CD25 and CD11c in all cases, while positivity was seen for CD79b in 93.7 per cent, kappa light chain restriction in 60 per cent and lambda in 40 per cent cases. Notably, 20 per cent showed CD10 and 12 per cent showed CD23 expression. INTERPRETATION &
CONCLUSIONS: This study reveals some unusual findings in otherwise classical disease entity, like absence of palpable spleen, presence of lymphadenopathy, normal or elevated leukocyte counts, expression of CD10, which at times could be diagnostically challenging.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26609034      PMCID: PMC4683827          DOI: 10.4103/0971-5916.169204

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  16 in total

Review 1.  [Hairy-cell leukemia: 30 cases and a review of the literature].

Authors:  Jean-Valère Malfuson; Olivier Gisserot; Serge Cremades; Kamal Doghmi; Thierry Fagot; Bertrand Souleau; Thierry de Revel; Jean-Pierre de Jaureguiberry; Gérard Nedellec
Journal:  Ann Med Interne (Paris)       Date:  2003-11

2.  Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.

Authors:  B A Robbins; D J Ellison; J C Spinosa; C A Carey; R J Lukes; S Poppema; A Saven; L D Piro
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

3.  Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes.

Authors:  R N Miranda; J B Cousar; R D Hammer; R D Collins; C L Vnencak-Jones
Journal:  Hum Pathol       Date:  1999-03       Impact factor: 3.466

4.  Clinico-pathological profile of Hairy cell leukemia: critical insights gained at a tertiary care cancer hospital.

Authors:  Komal S Galani; P G Subramanian; Vijaya S Gadage; Khaliqur Rahman; M S Ashok Kumar; Shaila Shinde; Shashikant Mahadik; Rashida Ansari; Manju Sengar; Hari Menon; Reena Nair; Sumeet Gujral
Journal:  Indian J Pathol Microbiol       Date:  2012 Jan-Mar       Impact factor: 0.740

5.  Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.

Authors:  Grant R Goodman; Carol Burian; James A Koziol; Alan Saven
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

6.  Hairy cell leukemia (leukemic reticuloendotheliosis). I. A clinical pathologic study of 21 patients.

Authors:  J S Burke; G E Byrne; H Rappaport
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

Review 7.  Leukemic reticuloendotheliosis (hairy cell leukemia).

Authors:  B A Bouroncle
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

8.  Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1).

Authors:  Brunangelo Falini; Enrico Tiacci; Arcangelo Liso; Katia Basso; Elena Sabattini; Roberta Pacini; Robin Foa; Alessandro Pulsoni; Riccardo Dalla Favera; Stefano Pileri
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

9.  Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine.

Authors:  G Juliusson; R Lenkei; J Liliemark
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

10.  Hairy cell leukemia: a clinical review based on 71 cases.

Authors:  H M Golomb; D Catovsky; D W Golde
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

View more
  3 in total

1.  "Hairy Cell Leukemia (HCL): 'Real World' Outcome".

Authors:  Archit Joshi; Manikandan Dhanushkodi; Prasanth Ganesan; Venkatraman Radhakrishnan; Krishnarathinam Kannan; Nikita Mehra; Jayachandran Perumal Kalaiyarasi; S Krupashankar; Shirley Sundersingh; T S Ganesan; T G Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-28       Impact factor: 0.900

2.  Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years.

Authors:  Fergün Yılmaz; Dilan Atilla; Nagihan Akkaş; Hale Bülbül; Nur Soyer; Derya Demir; Demet Kiper; Aylin Avcı; Filiz Vural; Güray Saydam; Fahri Şahin; Mine Hekimgil; Nazan Özsan; Raika Durusoy; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-05-13       Impact factor: 0.900

Review 3.  CD11c+ T-bet+ memory B cells: Immune maintenance during chronic infection and inflammation?

Authors:  Gary M Winslow; Amber M Papillion; Kevin J Kenderes; Russell C Levack
Journal:  Cell Immunol       Date:  2017-07-19       Impact factor: 4.868

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.